Time Magazine's Alice Park wrote a bizarre "letter' in JAMA, which apparently hoped to scare us about a group that found more glyphosate in urine samples than they expected. Her primary source: A guy with a "Ph.D" from an unaccredited institution who writes about yogic flying and ghosts.

Gov. Andrew Cuomo has signed legislation banning the use of electronic cigarettes indoors. It's a move that ensures his position as being pro-cancer and anti-science.

The glyphosate scandal involving the International Agency for Research on Cancer has severely – and perhaps irreparably – damaged the reputation of the World Health Organization. Sixteen scientists contacted by Reuters refused to answer any questions about the glyphosate document. That's not how science operates; that's how Fight Club operates.

Another underwater birth, another near-fatal consequence. This time the imperiled, septic newborn endured unnecessary multi-organ failure, which necessitated a two-month hospitalization in intensive care.

Just three business days after getting the FDA's green light, Shingrix, a more effective shingles vaccine, will go before the Centers for Disease Control on Wednesday. A committee is expected to vote, formally recommending how often the vaccine should be administered, and to what age group.

Financial conflicts of interest are of increasing concern. And when this occurs, the response from medical leadership, authors and publishers must be disclosure. Here we shed some sunlight on how well we adhere to our self-imposed standards.

This latest story refers to dogs' affinity for humans — even strange ones. New research demonstrates that dogs react more strongly when a person is facing them than when they turn away. And that reaction isn't changed by the presence of food. 
 

A four-time Iditarod champ has been accused of doping some of his dogs with a painkiller. Tramadol, an atypical opioid, has some properties in common with the traditional opioids like morphine, which makes this interesting both medically and scientifically. How does it work? It is not as restricted as Vicodin, nor should it be. Here's why. 

People who see corporate shills everywhere they look are no different from run-of-the-mill conspiracy theorists. And some of them are MDs.

Two months after the first gene therapy for cancer was approved by the Food and Drug Administration, there is now another. Known as Yescarta, it will be used to treat adults with a type of non-Hodgkin lymphoma, large B-cell lymphoma, who have failed to respond to other treatments.